Literature DB >> 3951394

Detection of retroviral particles in hybridomas secreting monoclonal antibodies.

A H Bartal, C Feit, R A Erlandson, Y Hirshaut.   

Abstract

Electronmicroscopy of hybridoma clones derived by fusing BALB/c mouse spleen cells with P3U1 mouse plasmacytoma cells to generate monoclonal antibodies against human sarcoma antigens, revealed the presence of large number of viral particles. These particles were also seen budding from the cell surfaces. The intracytoplasmic particles were intracisternal and resembled type-A oncornavirus, while the budding and extracellular forms, with a centrally located nucleoid, resembled mature type-C oncornaviruses. Cells of the parental P3U1 palsmacytoma cell line and of the NS-1 myeloma cell line contained morphologically identical viral structures. The scientific and medical communities engaged in hybridoma research should be alert to the possible presence of viruses in hybridomas and their products. The question is raised as to whether it is safe to use mouse monoclonal antibodies for clinical purposes, both diagnostic and therapeutic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951394     DOI: 10.1007/bf02123685

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  15 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Viral particles in hybridoma clones secreting monoclonal antibodies.

Authors:  C Rozman; R Vdilella; J Vives
Journal:  Lancet       Date:  1982-08-21       Impact factor: 79.321

3.  Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

Authors:  R A Miller; D G Maloney; R Warnke; R Levy
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

4.  Tumor therapy with monoclonal antibodies.

Authors:  R Levy; R A Miller
Journal:  Fed Proc       Date:  1983-06

5.  Oncoviruses and monoclonal antibody production.

Authors:  D Thornton; R A Nicholas
Journal:  Vet Rec       Date:  1982-10-02       Impact factor: 2.695

6.  In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia.

Authors:  R A Miller; D G Maloney; J McKillop; R Levy
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

7.  Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen.

Authors:  L M Nadler; P Stashenko; R Hardy; W D Kaplan; L N Button; D W Kufe; K H Antman; S F Schlossman
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

8.  Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

Authors:  J Ritz; J M Pesando; S E Sallan; L A Clavell; J Notis-McConarty; P Rosenthal; S F Schlossman
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

9.  An enzyme-linked immunosorbent assay (ELISA) for the detection of monoclonal antibodies recognizing surface antigens expressed on viable cells.

Authors:  C Feit; A H Bartal; G Tauber; G Dymbort; Y Hirshaut
Journal:  J Immunol Methods       Date:  1983-03-25       Impact factor: 2.303

10.  A NEW MAGAGLAS, D.E.R.(R) 732, EMBEDMENT FOR ELECTRON MICROSCOPY.

Authors:  R A ERLANDSON
Journal:  J Cell Biol       Date:  1964-09       Impact factor: 10.539

View more
  1 in total

1.  Endogenous retrovirus particles and their repercussion effects on the growth behaviour of continuous hybridoma cultivation processes.

Authors:  A Hawerkamp; F Gudermann; A Falkenhain; D Luetkemeyer; U Kahmann; J Lehmann
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.